This year marks a significant milestone for RQMIS—30 years of helping life sciences companies navigate the complex world of regulatory, clinical, and quality strategy.
Founded by Barry Sands, RQMIS was built on a clear vision: to provide expert guidance that empowers organizations to bring safe, effective, and innovative medical technologies to market. Over the past three decades, that vision has translated into a trusted global partner for companies ranging from early-stage startups to established industry leaders.
Throughout its history, RQMIS has remained at the forefront of an ever-evolving regulatory landscape. From supporting critical FDA submissions to developing comprehensive global strategies, the team has consistently delivered solutions that are both practical and forward-thinking. This adaptability has been key—not just to staying relevant, but to leading in a space where change is constant and stakes are high.
What truly sets RQMIS apart is its people. Under Barry’s leadership, the organization has cultivated a team of experienced professionals who bring deep technical knowledge, strategic insight, and a shared commitment to client success. This combination has enabled RQMIS to build long-standing relationships and play a meaningful role in advancing healthcare innovation worldwide.
Reaching 30 years in business is no small feat—especially in an industry defined by complexity and rapid change. It reflects not only resilience, but also a relentless focus on quality, integrity, and results.
As RQMIS looks to the future, the mission remains the same: to guide clients through regulatory challenges with confidence and clarity, and to continue making a positive impact on global health.
Congratulations to Barry Sands and the entire RQMIS team on this remarkable achievement—and here’s to the next chapter of growth and innovation.